CTLA4 Single-Nucleotide Polymorphisms Influence the Risk of HSV and VZV Infection in Kidney Transplant Recipients: A Prospective Cohort Study
Authors:
Open Access
- 21 May 2025
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 38, 14648
Abstract
Herpesviruses are able to modulate adaptive T-cell-mediated responses to establish latency within the host. Reactivation of herpes simplex virus (HSV)-1/2 and varicella zoster virus (VZV) is a frequent and potentially serious complication among kidney transplant recipients (KTRs). The ability of clinical criteria to identify KTRs at increased risk of α-herpesvirus (HSV/VZV) infection is limited. We investigated the effect of two single nucleotide polymorphisms (SNPs) in the cytotoxic T-lymphocyte antigen 4 (CTLA4) gene in a single-center cohort of 204 KTRs. After a median follow-up of 3.1 years, 34 of them (16.7%) experienced 22 episodes of zoster and 15 episodes of HSV-1/2 infection. Homozygous carriers of the minor allele of rs231775 had a higher cumulative incidence of α-herpesvirus infection (23.5% for GG versus 7.6% for AA/AG carriers; P-value = 0.011) and a lower infection-free survival (log-rank P-value = 0.037). After multivariable adjustment by clinical factors (including use of valganciclovir prophylaxis and acute rejection as time-dependent variables), the GG genotype of CTLA4 (rs231775) SNP was associated to the study outcome (adjusted hazard ratio: 3.21; 95% confidence interval: 1.44–7.16). In conclusion, genetic polymorphisms in the co-inhibitory T-cell receptor CTLA-4 may be detrimental for the immune control of latent HSV/VZV infection in KTRs.Keywords
This publication has 29 references indexed in Scilit:
- Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) in Solid Organ Transplant PatientsAmerican Journal of Transplantation, 2013
- Association of genetic polymorphisms and risk of late post-transplantation infection in pediatric heart recipientsThe Journal of Heart and Lung Transplantation, 2010
- CTLA-4 Control over Foxp3 + Regulatory T Cell FunctionScience, 2008
- Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of CancerCancer Research, 2008
- Recipient cytotoxic T lymphocyte antigen‐4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patientsLiver International, 2007
- Clinical Diagnosis of Herpes Zoster in Family PracticeThe Annals of Family Medicine, 2007
- CTLA-4: new insights into its biological function and use in tumor immunotherapyNature Immunology, 2002
- CTLA-4 Suppresses Proximal TCR Signaling in Resting Human CD4+ T Cells by Inhibiting ZAP-70 Tyr319 Phosphorylation: A Potential Role for Tyrosine PhosphatasesThe Journal of Immunology, 2002
- CTLA-4 gene expression is influenced by promoter and exon 1 polymorphismsGenes & Immunity, 2001
- CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.Journal of Experimental Medicine, 1995